Viewing Study NCT01589367


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2025-12-25 @ 10:40 PM
Study NCT ID: NCT01589367
Status: COMPLETED
Last Update Posted: 2018-09-10
First Post: 2012-04-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer
Sponsor: Seoul National University Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: KBCSG 013
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators